Close Menu

NEW YORK — Canopy Biosciences said today it has acquired biopharma services firm Core Diagnostics.

With the purchase, St. Louis, Missouri-based Canopy acquires Core's CLIA facility, from which it will provide its multi-omic immune profiling services.

Core also offers NanoString transcriptional profiling and histopathology services including immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.